216 related articles for article (PubMed ID: 12894095)
21. Longitudinal melanonychia induced by hydroxyurea: four case reports and review of the literature.
Delmas-Marsalet B; Beaulieu P; Teillet-Thiebaud F; Jary L; Teillet F
Nouv Rev Fr Hematol (1978); 1995; 37(3):205-10. PubMed ID: 7567439
[TBL] [Abstract][Full Text] [Related]
22. Hydroxyurea-induced fever in a patient with chronic myelogenous leukemia.
Tsurumi H; Goto H; Hara T; Moriwaki H
Int J Hematol; 2000 Oct; 72(3):386-7. PubMed ID: 11186000
[No Abstract] [Full Text] [Related]
23. Gottron's papules-like eruption developing under hydroxyurea therapy.
Slobodin G; Lurie M; Munichor M; Kovalev J; Rosner I
Rheumatol Int; 2006 Jun; 26(8):768-70. PubMed ID: 16583187
[TBL] [Abstract][Full Text] [Related]
24. A case of hydroxyurea-induced longitudinal melanonychia.
Utaş S; Kulluk P
Int J Dermatol; 2010 Apr; 49(4):469-70. PubMed ID: 20465711
[No Abstract] [Full Text] [Related]
25. Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia.
Deguchi N; Kawamura T; Shimizu A; Kitamura R; Yanagi M; Shibagaki N; Matsue H; Shimada S
Br J Dermatol; 2006 Jun; 154(6):1216-8. PubMed ID: 16704666
[No Abstract] [Full Text] [Related]
26. Hydroxyurea-induced foot ulcer successfully treated with a topical basic fibroblast growth factor product.
Aragane Y; Okamoto T; Yajima A; Isogai R; Kawada A; Tezuka T
Br J Dermatol; 2003 Mar; 148(3):599-600. PubMed ID: 12653764
[No Abstract] [Full Text] [Related]
27. Multiple longitudinal pigmented nail bands during hydroxyurea therapy.
Kelsey PR
Clin Lab Haematol; 1992; 14(4):337-8. PubMed ID: 1478015
[No Abstract] [Full Text] [Related]
28. Longitudinal melanonychia in a patient with essential thrombocytosis under treatment with hydroxyurea.
Clerico R; Corsetti P; Ambrifi M; Paolino G; Rossi MR; Bottoni U; Calvieri S
Acta Dermatovenerol Croat; 2012; 20(4):281-3. PubMed ID: 23317494
[No Abstract] [Full Text] [Related]
29. Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis.
Varma S; Lanigan SW
Clin Exp Dermatol; 1999 May; 24(3):164-6. PubMed ID: 10354169
[TBL] [Abstract][Full Text] [Related]
30. Dermatomyositis-like eruption following hydroxyurea therapy.
Rocamora V; Puig L; Alomar A
J Eur Acad Dermatol Venereol; 2000 May; 14(3):227-8. PubMed ID: 11032076
[No Abstract] [Full Text] [Related]
31. Images in clinical medicine. Acquired melanonychia.
Ranta D; Bonmati C
N Engl J Med; 2009 Sep; 361(12):1188. PubMed ID: 19759381
[No Abstract] [Full Text] [Related]
32. Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema.
Ito E; Muro Y; Shibata A; Sugiura K; Akiyama M
Dermatol Online J; 2014 Aug; 20(8):. PubMed ID: 25148281
[TBL] [Abstract][Full Text] [Related]
33. Dermatomyositis-like eruption induced by hydroxyurea: a case report.
Janerowicz D; Czarnecka-Operacz M; Stawny M; Silny W
Acta Dermatovenerol Alp Pannonica Adriat; 2009 Sep; 18(3):131-4. PubMed ID: 19784527
[TBL] [Abstract][Full Text] [Related]
34. Mucocutaneous lesions and nail pigmentation in a patient with essential thrombocytosis.
Calleja Algarra A; Miguel RA; Tous Romero F; Maroñas Jiménez L
Aust Fam Physician; 2017; 46(4):222-224. PubMed ID: 28376576
[No Abstract] [Full Text] [Related]
35. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
Tripathi AK; Ahmad R; Sawlani KK
J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
[TBL] [Abstract][Full Text] [Related]
36. Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiation exposure.
Kalajian AH; Cely SJ; Malone JC; Burruss JB; Callen JP
Arch Dermatol; 2010 Mar; 146(3):305-10. PubMed ID: 20231502
[TBL] [Abstract][Full Text] [Related]
37. Horizontal melanonychia.
Salman A; Eser A; Kaygusuz Atagunduz I; Ergun T
Actas Dermosifiliogr; 2017 Jun; 108(5):469-470. PubMed ID: 27543192
[No Abstract] [Full Text] [Related]
38. Hydroxyurea-induced dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea.
Kirby B; Rogers S
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):781-2. PubMed ID: 9591832
[No Abstract] [Full Text] [Related]
39. Imatinib: a designer drug, another cutaneous complication.
Dickens E; Lewis F; Bienz N
Clin Exp Dermatol; 2009 Jul; 34(5):603-4. PubMed ID: 19486036
[TBL] [Abstract][Full Text] [Related]
40. Blue lunula due to hydroxyurea.
Jeevankumar B; Thappa DM
J Dermatol; 2003 Aug; 30(8):628-30. PubMed ID: 12928534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
